Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry
August 20, 2021 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 20 August 2021 at 9 AM (EEST) Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry...
Worldwide Depression Treatment Industry to 2026 - Increasing Awareness About Mental Illness is Accelerating Market Growth
August 05, 2021 07:58 ET
|
Research and Markets
Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Depression Treatment Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The rising prevalence of depression among the...
Global Bipolar Depression Market Research Report 2021
August 03, 2021 05:33 ET
|
Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Bipolar Depression - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This 'Bipolar...
Nexstim Receives an NBS System Upgrade Order from a University Hospital in Finland
July 16, 2021 02:00 ET
|
Nexstim Oyj
Press Release, Helsinki, 16 July 2021 at 9:00 PM (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received a new NBS System upgrade order from a university...
Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50%
June 21, 2021 03:30 ET
|
Nexstim Oyj
Press Release, Helsinki, June 21, 2021 at 10:30 AM (EEST) Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50% Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland
April 29, 2021 03:00 ET
|
Nexstim Oyj
Press Release, Helsinki, 29 April 2021 at 10:00 AM (EEST) Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Plc Business and Clinical Update Q1 2021
April 22, 2021 05:00 ET
|
Nexstim Oyj
Press release, Helsinki, 22.04.2021, 12.00 pm (EEST) Nexstim Plc Business and Clinical Update Q1 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the key highlights of...
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
April 16, 2021 05:00 ET
|
Nexstim Oyj
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX,...
Psilocybin Mushrooms Use For Mental Health Research By The Recover
April 12, 2021 03:00 ET
|
The Recover
HUNTINGTON BEACH, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- The Recover, a national news provider for mental health and substance abuse, recently began releasing news about psilocybin and their...
Depression Treatment Therapy Market 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast Report 2021-2028
April 07, 2021 09:13 ET
|
Fortune Business Insights
Pune, India, April 07, 2021 (GLOBE NEWSWIRE) -- The global ”depression treatment therapy market” size is expected to gain momentum backed by the increasing incidence of suicides and the growing...